CENIT AG

GBC AG Reiterates Buy Rating and Maintains Target Price for CENIT AG

GBC AG has reaffirmed its ‘BUY’ rating on CENIT AG, maintaining a price target of €16.00 through December 31, 2026. The company reported a slight revenue increase of 1.8% to €154.2 million, mainly due to the acquisition of Analysis Prime. Despite challenges in the automotive sector, CENIT AG expects positive earnings contributions from Analysis Prime starting in 2026. GBC AG has adjusted its EBIT expectations upward for the current year while keeping revenue estimates unchanged.

Reuters

GBC AG Maintains CENIT AG 'BUY' Rating With €16.00 Price Target

CENIT AG reported Q3 EBIT of 2.2 million euros, with sales of 154.2 million euros for the nine-month period, reflecting a 1.8% increase year-over-year. Third-party software sales fell by 1.8%, while CENIT's own software sales rose by 3.8%. Consulting and services sales grew by 5.7%. Despite a gross profit increase of 4.6%, EBITDA dropped by 45.7%, and EBIT was -1.5 million euros due to one-off expenses and acquisition losses. The equity ratio stood at 27.5%, with 914 employees.

CENIT AG reports Q3 EBIT of 2.2 million euros on sales of 154.2 million euros

CENIT AG board member Peter Schneck has purchased shares worth EUR 4,093.20 at a price of 7.58 EUR per share. This transaction highlights insider activity within the company. The information was originally published by CENIT AG via EQS News on September 18, 2025.

CENIT AG Board Member Peter Schneck Purchases Shares Worth EUR 4,093.20

Peter Schneck, a member of the managing body at CENIT AG, has acquired shares worth 34,807.60 EUR at prices of 7.40 EUR, 7.36 EUR, and 7.58 EUR. This transaction reflects his investment in the company. The information was published by CENIT AG via EQS News on September 17, 2025.

Peter Schneck, Member of the Managing Body, purchased shares worth 34,807.60 EUR

CENIT AG announced that Dr. Johannes Fues, a member of its managing body, has acquired shares in the company. The transaction took place on August 21, 2025, with an aggregated volume of 25,045.14 EUR at an average price of 7.4142 EUR per share. This notification is part of the regulatory disclosure of transactions by persons in managerial positions.

CENIT AG: Dr. Johannes Fues, buy

CENIT AG disclosed that Dr. Johannes Fues, a board member, purchased shares on August 21, 2025, on the Tradegate exchange. The shares were bought at prices of 7.404235 EUR and 7.418499 EUR, totaling 25,045.14 EUR at an average price of 7.4142 EUR. This internal dealing was reported on August 26, 2025, via EQS News.

CENIT AG: Dr. Johannes Fues Reports Purchase in Internal Dealing Disclosure

Montega AG has reiterated its "buy" rating for CENIT AG but has lowered the price target from €15.00 to €13.00 due to a reduction in CENIT's annual revenue and earnings projections. The company now expects revenues of at least €205.0 million, down from €229.0 - €234.0 million, and a negative EBIT of over -€1.5 million, compared to the previous estimate of €6.8 - €7.3 million. The modest first-half revenue growth of 4.3% was mainly driven by the software business, while anticipated growth from Analysis Prime did not meet expectations.

Montega AG Reiterates "Buy" Rating for CENIT AG, Lowers Price Target to €13.00

CENIT AG reported record half-year sales of 103.7 million EUR, a 4.4% increase from last year. However, the company faced an EBIT loss of -3.7 million EUR due to challenges from its US subsidiary Analysis Prime and economic factors affecting customer behavior. The acquisition of Analysis Prime negatively impacted results by approximately -1.6 million EUR, while the transformation of the PLM segment contributed around -3.8 million EUR to the loss. Despite these challenges, CENIT AG maintains its full-year forecast, expecting revenues of at least 205.0 million EUR and an EBIT of at least -1.5 million EUR, indicating a temporary slowdown in business.

CENIT AG Reports Record Half-Year Sales of 103.7 mEUR, Faces EBIT Loss of -3.7 mEUR Amid Economic Challenges

CENIT AG has appointed Dr. Johannes Fues as the new Chief Financial Officer (CFO) and Chief Transformation Officer (CTrO), effective July 1, 2025. He will be responsible for the company's financial management and strategic transformation. Dr. Fues has previously held positions on the board of Kontron AG and served as CFO of KATEK SE.